Periactin and Bactroban drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Periactin (cyproheptadine hydrochloride) and Bactroban (mupirocin). Common drug interactions include pyrexia among females and acute respiratory failure among males.
The phase IV clinical study analyzes what interactions people have when they take Periactin and Bactroban. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.
What is Periactin?
Periactin has active ingredients of cyproheptadine hydrochloride. It is often used in migraine. eHealthMe is studying from 2,214 Periactin users. Check the latest studies of Periactin.
What is Bactroban?
Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,967 Bactroban users. Check the latest studies of Bactroban.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
19 people who take Periactin and Bactroban together, and have interactions are studied.

What are the common drug interactions of Periactin and Bactroban, by gender? *:
female:
- Pyrexia (fever)
- Asthma
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Cystic fibrosis (disease of the secretary glands)
- Headache (pain in head)
- Insomnia (sleeplessness)
- Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
- Visual acuity reduced (reduced clearness of vision)
male:
- Acute respiratory failure
- Pyrexia (fever)
- Dyspnoea (difficult or laboured respiration)
- Feeling hot
- Flushing (the warm, red condition of human skin)
- Influenza
- Infusion site pain
- Pneumonia
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Pulmonary oedema (fluid accumulation in the lungs)
What are the common drug interactions of Periactin and Bactroban, by age (0-1 to 60+)? *:
0-1:
- Acute respiratory failure
- Pyrexia (fever)
- Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs)
- Catheter site discharge
- Catheter site haemorrhage (bleeding at catheter site)
- Catheter site pain
- Catheter site swelling
- Corona virus infection (infection caused by a corona virus)
- Dyspnoea (difficult or laboured respiration)
- Feeling hot
2-9:
- Asthma
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Pyrexia (fever)
- Cystic fibrosis (disease of the secretary glands)
- Peritonitis bacterial (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs by bacterial)
- Visual acuity reduced (reduced clearness of vision)
10-19:
- Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
- Agitation (state of anxiety or nervous excitement)
- Atrophy (wasting away of a part of the body)
- Bone formation increased
- Cardiac failure
- Constipation
- Headache (pain in head)
- Implant site pain
- Insomnia (sleeplessness)
- Irritability
20-29:
n/a
30-39:
- Application site erythema (redness of the skin at application site)
- Application site pain
- Application site rash
- Application site urticaria
- Application site vesicles (small bubble within a cell at application site)
- Headache (pain in head)
- Insomnia (sleeplessness)
40-49:
n/a
50-59:
- Dyslipidaemia (abnormal amount of lipids)
- Hypertension (high blood pressure)
- Lymphoedema (localized fluid retention and tissue swelling)
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally)
- Nipple exudate bloody (discharge from nipple with blood)
- Overweight
- Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
- Type 2 diabetes mellitus
- Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
60+:
- Cardiac failure congestive
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Hyperhidrosis (abnormally increased sweating)
- Inferior vena caval occlusion
- Pain in extremity
- Pulmonary oedema (fluid accumulation in the lungs)
- Renal failure chronic (long lasting kidney dysfunction)
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
What are the existing conditions these people have? *
- Asthma: 6 people, 31.58%
- Cystic Fibrosis (disease of the secretary glands): 5 people, 26.32%
- High Blood Pressure: 3 people, 15.79%
- Allergic Rhinitis: 3 people, 15.79%
- Fungal Infection: 3 people, 15.79%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 15.79%
- Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 3 people, 15.79%
- Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 3 people, 15.79%
- Muscle Spasms (muscle contraction): 2 people, 10.53%
- Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 2 people, 10.53%
* Approximation only. Some reports may have incomplete information.
Do you take Periactin and Bactroban?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Periactin and Bactroban:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Periactin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Bactroban:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Periactin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bactroban and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cyproheptadine hydrochloride and mupirocin (the active ingredients of Periactin and Bactroban, respectively), and Periactin and Bactroban (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ibu vs. Lyrica, side effect and effectiveness comparison - 4 seconds ago
- Could Botox cause Hallucination, Visual? - 23 seconds ago
- Schizophrenia and Depression - 23 seconds ago
- Drug interactions of Lithium Carbonate and Naltrexone Hydrochloride - 39 seconds ago
- Could Magnesium Sulfate cause Gastritis? - 46 seconds ago
- Primary Pulmonary Hypertension and Colitis - 47 seconds ago
- Drug interactions of Escitalopram and Metformin Hydrochloride - 48 seconds ago
- Plasmacytoma and Diarrhea - 54 seconds ago
- Plasmacytoma and Stools - Watery - 54 seconds ago
- Could Enbrel cause Extremity Necrosis? - 56 seconds ago